NCT03607396 Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis Status UNKNOWN Phase N/A
NCT03602560 ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) Status COMPLETED Phase PHASE3
NCT03595527 Universal HIV Screening and Targeted HCV Screening in Emergency Department Status COMPLETED Phase NA
NCT03582098 Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland Status COMPLETED Phase N/A
NCT03581383 Community Access, Retention in Care, and Engagement for Hepatitis C Treatment Status COMPLETED Phase NA
NCT03580668 Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide Status COMPLETED Phase N/A
NCT03577197 Southeast Netherlands Advanced Metastatic Breast Cancer Registry Status RECRUITING Phase N/A
NCT03568929 Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma Status COMPLETED Phase N/A
NCT03558139 Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy Status COMPLETED Phase PHASE1
NCT03551522 A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH) Status TERMINATED Phase PHASE2
NCT03549312 Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy Status UNKNOWN Phase PHASE4
NCT03547973 Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread Status RECRUITING Phase PHASE2
NCT03547908 Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults Status COMPLETED Phase PHASE3
NCT03532425 B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults Status TERMINATED Phase PHASE4
NCT03512418 Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps) Status COMPLETED Phase PHASE3
NCT03502005 Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1 Status COMPLETED Phase PHASE4
NCT03498625 Crohn's Disease Endoscopic REmission Definition in an Objective Way Status COMPLETED Phase NA
NCT03493568 Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE) Status TERMINATED Phase PHASE3
NCT03491553 Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B Status COMPLETED Phase PHASE2